Ophthalmopathy
Conditions
Keywords
Full Thickness Macular Hole, Blood Clot, Whole blood, Pars-pana vitrectomy
Brief summary
Autologous blood for primary and recurrent holes
Detailed description
Utilizing whole autologous blood for closing both primary and recurrent holes. Here, we apply a drop of the taken whole blood over the hole, and the access blood will be aspirated on the macula with a silicon-tipped active back-flash cannula, to abolish all the possibilities of the fibrinogenic behavior of the whole blood composition, which might cause traction and recurrent hole formation. Therefore, only the hole will be filled with blood. The blood will be taken under completely sterile and aseptic conditions. The air infusion will be raised after the valve of one of the trocars will be removed, to allow the air current to dry the clot inside the hole rapidly. Then air gas exchange will be performed to allow the clot to remain away from intraocular fluids for one to two weeks and abolish the possibility of the clot being dissolved.
Interventions
OTHERPars-plana vitrectomy
Pars-plana vitrectomy
Sponsors
Omer Othman Abdullah
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Primary and recurrent holes
Exclusion criteria
* Lamellar and pseudoholes
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Anatomical outcome | The fourth week post-operatively | OCT |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Functional outcome | The fourth week post-operatively. | Best corrected visual acuity |
Countries
Iraq
Outcome results
None listed